Advertisement
Advertisement
U.S. Markets close in 43 mins
Advertisement
Advertisement
Advertisement
Advertisement

Pulse Biosciences, Inc. (PLSE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9677+0.0277 (+1.43%)
As of 03:16PM EDT. Market open.
Advertisement
Full screen
Loading interactive chart...
  • Business Wire

    Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    HAYWARD, Calif., June 16, 2022--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to three new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Equity Incentive Plan. The equity awards were approved and issued

  • Business Wire

    Pulse Biosciences, Inc. Announces the Closing of Its Rights Offering

    HAYWARD, Calif., June 09, 2022--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, announced today the closing of its rights offering and the final results thereof.

  • Business Wire

    Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering

    HAYWARD, Calif., June 03, 2022--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, announced today preliminary results of its rights offering, which expired at 5:00 p.m., Eastern Time, on May 26, 2022 (the "Expiration Date").

Advertisement
Advertisement